Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPREX (epoetin alfa) to reduce transfusion requirements in hip replacement surgery
NCT00269971Phase 3Withdrawn
- Sponsor
- Janssen Ortho
- Start
- May 1996
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Janssen Ortho. Planned start May 1996; status: withdrawn.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00269971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269971.